Dosimetric analysis of plans using x-ray and γ-ray combination strategy for advanced cervical cancer patients with pelvic lymph node metastasis

The dual-modality system has the potential to enhance treatment outcomes in CC by optimizing tumor coverage while reducing toxicity. Future clinical trials should assess its impact on patient survival and treatment-related side effects to bridge the gap between dosimetric improvements and clinical application.